Latent View Analytics Records Highest Single Day Volume In A Year - Here’s Why

On April 2, 2026, Latent View Analytics share price closed at Rs 312.10, up 19.49 per cent for the session. The stock opened at Rs 259.90, touched an intraday high of Rs 313.40, and held a low of Rs 256.75 during the day. The session also recorded the highest single-day trading volume in over a year, with 643.5 lakhs shares as compared to 30 day average volume of 29 lakhs shares

The stock had been under pressure in the recent months. It had corrected 51 per cent from its recent high of Rs 517.50 and hit an all time low of Rs 248 on March 23, 2026. The April 2 session saw the stock recover from those levels, driven by a strategic investment announcement made by the company on the same day.

Latent View New Investment
Latent View Analytics announced that its wholly owned US subsidiary, Latent View Analytics Corporation, had completed a USD 3 million investment in Healtheon AI. The investment was made through a SAFE note, which stands for Simple Agreement for Future Equity. This means Latent View has given USD 3 million to Healtheon AI today, and in return will receive equity shares in the company at a future date, typically when Healtheon AI raises its next funding round. The entire USD 3 million was transferred in a single installment.

Healtheon AI builds AI-based solutions for the healthcare Revenue Cycle Management sector, commonly referred to as RCM. Healthcare RCM is the set of financial processes that run behind every patient visit. This includes checking insurance eligibility, getting approvals for treatments, assigning medical codes, submitting claims to insurers, and following up on payments that are rejected or delayed. These tasks are time consuming, expensive, and handled largely by people, making them one of the biggest sources of administrative cost in the healthcare system.

Healtheon AI addresses this by deploying specialised AI agents that work across the entire revenue cycle at the same time. Rather than automating one task at a time, these agents handle eligibility checks, coding, claims processing, and payment recovery simultaneously, working alongside human teams rather than replacing them. The system is designed to process at scale in real time and commits to measurable reductions in labour costs and revenue leakage through performance-based contracts.

Beyond the financial investment, Latent View will serve as a preferred deployment partner for Healtheon AI. This means Latent View's data analytics capabilities will be used together with Healtheon AI's platform to deliver solutions to healthcare providers, health systems, and payors. The investment is part of Latent View's broader strategy of building, investing, and partnering to become an AI-first organisation.

New investment in AI agentic
Adding to the activity, four institutional players purchased shares in Latent View Analytics on the NSE. NK Securities Research Private Limited was the largest buyer, acquiring 29,49,581 shares. Junomoneta Finsol Private Limited purchased 13,42,872 shares. Societe Generale acquired 10,79,020 shares, and Mathisys Advisors LLP bought 10,37,429 shares. Together, the four institutions collectively acquired over 64 lakh shares in a single session.

About Latent View Analytics
Latent View Analytics is a global data analytics company that helps businesses use data to improve decision-making and performance. The company works with over 50 Fortune 500 companies across technology, CPG, industrials, financial services, and retail sectors. Its services include analytics, data engineering, and AI-driven consulting.

About Healtheon AI
Healtheon AI is building a fully autonomous agentic AI platform for healthcare revenue cycle management. The company's platform is designed to move the revenue cycle from reactive recovery to proactive prevention, reducing administrative waste and revenue leakage across the healthcare system.

Share your thoughts in the comments below.

Disclaimer: The article is for informational purposes only and not investment advice.